Can-Fite BioPharma Ltd. buy Lokrim
Start price
22.02.21
/
20%
€21.80
Target price
22.02.22
-
Performance (%)
-46.79%
End price
14.11.21
€11.60
Summary
This prediction ended on 14.11.21 with a price of €11.60. The BUY prediction by Lokrim for Can-Fite BioPharma Ltd. performed very badly with a performance of -46.79%. Lokrim has 20% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Can-Fite BioPharma Ltd. | - | - | - | - |
iShares Core DAX® | 2.749% | 4.620% | 17.121% | 21.210% |
iShares Nasdaq 100 | 0.470% | -0.331% | 37.776% | 57.865% |
iShares Nikkei 225® | -2.930% | -5.556% | 12.185% | 8.407% |
iShares S&P 500 | 0.679% | 0.631% | 28.996% | 48.197% |
According to Lokrim what are the pros and cons of Can-Fite BioPharma Ltd. for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
Comments by Lokrim for this prediction
In the thread Can-fite Biopharma Ltd. diskutieren
Buy Can-fite Biopharma Ltd.
In the thread Trading Can-fite Biopharma Ltd.
Buy beendet
Stopped prediction by Lokrim for Can-Fite BioPharma Ltd.
Can-Fite BioPharma Ltd.
Start price
Target price
Perf. (%)
€11.60
14.11.21
14.11.21
-
14.11.22
14.11.22
-33.62%
15.11.22
15.11.22
Probably not worthwhile Investment